Anti-dsDNA B-Cell ELISpot as a Monitoring and Flare Prediction Tool in SLE Patients
Anti-dsDNA autoantibodies quantification and complement levels are widely used to monitor disease activity in systemic lupus erythematosus (SLE). However, better biomarkers are still needed. We hypothesised whether the dsDNA antibody-secreting B-cells could be a complementary biomarker in disease ac...
Main Authors: | Albert Pérez-Isidro, Marc Xipell, Arturo Llobell, Noemí De Moner, Gema M. Lledó, Ricard Cervera, Sergio Prieto-González, Luis F. Quintana, Gerard Espinosa, Mila García-Ormaechea, Estíbaliz Ruiz-Ortiz, Odette Viñas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/4/1295 |
Similar Items
-
Correlation of Autoantibodies Presence Detected By IFA-anti-dsDNA, IFA-AMA and Immunoblotting with Corresponding Data in Clinical Management of Autoimmune Diseases
by: Đemo Subašić, et al.
Published: (2008-02-01) -
Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jSLE)
by: Valentina Natoli, et al.
Published: (2023-08-01) -
SLE classification criteria: Science-based icons or algorithmic distractions – an intellectually demanding dilemma
by: Ole Petter Rekvig, et al.
Published: (2022-09-01) -
Reversible dysregulation of renal circadian rhythm in lupus nephritis
by: Rakesh Mishra, et al.
Published: (2021-09-01) -
Co-positivity of anti-dsDNA, anti-nucleosome, and anti-smith autoantibodies as serological biomarkers for disease activity in systemic lupus erythematosus
by: Sahar Abdel-Rahman Elsayed, et al.
Published: (2022-02-01)